Cooperatieve Gilde Healthcare IV U.A.

10% owner at LAVA Therapeutics NV; 10% owner at NARI

Sold, on record
$175M
Dollars the filings state
Form 4 sales
4
Latest Oct 17, 2025
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale NARIPlan not stated
    Dec 4, 2020 2020

    Sold 95,127 shares at $64.93 ($6.2M)

    Cooperatieve Gilde Healthcare IV U.A., 10% owner

    Sold 1.3% of holdings ($487M position)7.4M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale NARIPlan not stated
    Mar 15, 2021 +101 days

    Sold 1.4M shares at $112.86 ($164M)

    Cooperatieve Gilde Healthcare IV U.A., 10% owner

    Sold 24.4% of holdings ($671M position)4.5M shares leftFiling

  3. 3 Form 4 sale LAVA Therapeutics NVNo plan
    Oct 14, 2025 +1674 days

    Sold 475,027 shares at $1.51 ($719k)

    Cooperatieve Gilde Healthcare IV U.A., 10% owner

    No 10b5-1 planSold 9% of holdings ($8M position)4.8M shares leftFirst sale on recordFiling

  4. 4 Form 4 sale LAVA Therapeutics NVUnusual
    Oct 17, 2025 +3 days

    Sold 2.9M shares at $1.47 ($4.2M)

    Cooperatieve Gilde Healthcare IV U.A., 10% owner

    No 10b5-1 planSold 59.6% of holdings ($7.1M position)1.9M shares leftFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Cooperatieve Gilde Healthcare IV U.A.
Source
Oct 17, 2025Oct 20, 2025LAVA Therapeutics NV10% ownerForm 4 sale2.9M$4.2M59.6%UnusualSEC
Oct 14, 2025Oct 15, 2025LAVA Therapeutics NV10% ownerForm 4 sale475,027$719k9.0%No planSEC
Mar 15, 2021Mar 16, 2021NARI10% ownerForm 4 sale1.4M$164M24.4%Plan not statedSEC
Dec 4, 2020Dec 4, 2020NARI10% ownerForm 4 sale95,127$6.2M1.3%Plan not statedSEC